-
Insmed Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
Post on 2/25/20
-
Antares Pharma to Report Fourth Quarter and Full Year 2019 Financial and Operating Results
Post on 2/25/20
-
Outlook Therapeutics Announces $10.2M Financings Priced At-The-Market
Post on 2/24/20
-
A Big Month Ahead for the FDA and Bristol-Myers Squibb
Post on 2/24/20
-
Is Merck a Better Buy After Announcing Spinoff?
Post on 2/24/20
-
Akari Therapeutics Announces Private Placement
Post on 2/23/20
-
BioXcel Therapeutics Prices Public Offering of Common Stock
Post on 2/23/20
-
Agile Therapeutics Prices $45M Underwritten Public Offering of Common Stock
Post on 2/23/20
-
Merck's Chief Digital Officer Leaves to Join Marriott
Post on 2/21/20
-
Is Merck & Co. Stock a Buy?
Post on 2/20/20
-
FDA Rejects New Dosing for Merck's Cancer Drug Keytruda
Post on 2/20/20
-
VSS Announces Investment in Ascent Behavioral Health
Post on 2/19/20
-
Johnson & Johnson Expands Pact With U.S. Government to Seek a Treatment for COVID-19
Post on 2/19/20
-
Pfizer Gains European Approval for Amyloidosis Drug Vyndaqel
Post on 2/19/20
-
Northwell Named to Fortune’s “100 Best Companies to Work For”
Post on 2/18/20
-
Affinity Dental Management Expands Footprint Into Metro New York
Post on 2/18/20
-
PTC Therapeutics Launches Sixth Annual STRIVE Awards Program for Advocacy Organizations in Duchenne Muscular Dystrophy
Post on 2/18/20
-
Better Buy: Biogen vs. Bristol-Myers Squibb
Post on 2/18/20
-
Merck's Ebola Vaccine Approved for Use in Four African Countries
Post on 2/18/20
-
Outlook Therapeutics Provides Business Update
Post on 2/17/20
-
The Benchmark Company Closes Public Offering of $5m for Seelos Therapeutics
Post on 2/17/20
-
Seelos Therapeutics Closes Public Offering of Common Stock
Post on 2/17/20
-
FDA Gives Bristol-Myers Squibb's CAR-T Liso-Cel a Priority Review
Post on 2/13/20
-
Merck Spins, And Falls: Why I Am More Bullish Than The Street
Post on 2/13/20
-
Zoetis Reports Q4 Financial Results, Slightly Beats Revenue Estimates
Post on 2/13/20
